Digital health technology company WellDoc has announced a partnership with health data platform Human API to integrate type 2 diabetes patient health data within WellDoc’s BlueStar digital therapeutic.
As part of the collaboration, Human API’s data platform will provide WellDoc with real-time access to comprehensive clinical patient data from its network of 15,000+ pharmacies, health systems and laboratories. The steady flow of data is shared within a highly secure environment that ensures protection of data and patient privacy.
Through the Human API Data Platform, enterprises and applications can access and analyze comprehensive clinical data in real-time on more than 175 million covered lives from the Human API Health Data Network – a real-time, digital data network of more than 15,000 health systems, hospitals, clinics, labs, pharmacies, devices, and mobile health applications.
WellDoc’s BlueStar digital therapeutic for adults with type 2 diabetes uses information entered by patients, such as blood glucose levels, to deliver helpful guidance, messages, educational tips, and motivation – in real time. By partnering with Human API, WellDoc will be able to seamlessly integrate medication, medical history and laboratory data from multiple sources with a patient’s consent but without requiring direct patient input – further optimizing the user experience and helping patients and their physicians make informed decisions.
“Through Human API’s work with industry leaders like WellDoc, we are providing unprecedented health data liquidity to create a more effective and personalized healthcare system and power frictionless, real time consumer and patient experiences,” said Andrei Pop, Chief Executive Officer of Human API in a statement.
